| 发明名称 |
CONCOMITANT DRUG |
| 摘要 |
<p>Provided is a combination drug. The present invention provides a pharmaceutical agent comprising (1) a HER2 inhibitor having a pyrrolopyrimidine skeleton or pyrazolopyrimidine skeleton, and (2) not less than one pharmaceutical agent selected from an mTOR inhibitor, a PI3 kinase inhibitor and a cMet inhibitor in combination.</p> |
| 申请公布号 |
EP2255830(A1) |
申请公布日期 |
2010.12.01 |
| 申请号 |
EP20090717592 |
申请日期 |
2009.03.02 |
| 申请人 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED |
发明人 |
OHTA, YOSHIKAZU;TAKAGI, SHINJI;YAGUCHI, MASAHIRO |
| 分类号 |
A61K45/06;A61K31/436;A61K31/4545;A61K31/519;A61K31/5377;A61P35/00;A61P43/00 |
主分类号 |
A61K45/06 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
